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Abstract 
Objectives 
Lung cancer surgery leads to long term survival for some patients but little is known 
about how patients decide whether to accept the associated surgical risks. The objective 
of this qualitative study was to explore patients’ attitudes to the risks associated with 
lung cancer surgery. 
Methods 
Fifteen patients with resectable lung cancer, recruited via multi-disciplinary team 
meetings at an English tertiary referral centre, participated in semi-structured interviews 
to explore their attitudes to the morbidity and mortality risks associated with lung cancer 
surgery. Transcripts were analysed using the framework method. 
Results 
Participants reported being ‘pleased’ to hear that they were suitable for surgery and felt 
that surgery was not a treatment to be turned down because they did not see any 
alternatives. Participants had some knowledge of perioperative risks, including mortality 
estimates; however, many voiced a preference not to know these risks and to let the 
medical team decide their treatment plan. Some found it difficult to relate the potential 
risks and complications of surgery to their own situation and appeared willing to accept 
high perioperative mortality risks. Generally, participants were willing to accept quite 
severe long-term postoperative breathlessness; however, it was apparent that many 
actually found this possibility difficult to imagine.  
Conclusion 
Patients do not necessarily wish to know details of risks associated with lung cancer 
surgery and may wish to defer decisions about treatment to their medical team. 
Investment in the doctor-patient relationship, particularly for the surgeon, is therefore 
important in the management of patients with lung cancer. 
 
 3 
Keywords 
Lung neoplasm; Thoracic surgery; Risk; Mortality; Morbidity; Qualitative Research. 
 4 
Introduction  
Lung cancer is frequently associated with a poor prognosis, but for those in whom 
surgical resection is possible there is potential for longer-term survival. The risks 
associated with surgery are predominantly those of early mortality; early, intermediate 
and long term morbidity; and tumour recurrence.(1-3) For patients with resectable lung 
cancer, the decision whether or not to have surgery lies with the multi-disciplinary team 
(MDT) and the patient. It is usually the surgeon who communicates an estimated level of 
risk, both of postoperative mortality and morbidity to the patient. Given the risk of death 
and morbidity related to surgical resection, and the potential for much longer-term 
survival if the tumour is resected, (3) it is important that we understand patients’ 
perceptions of risk and how much risk they may be willing to accept.  
We aimed to explore patients’ attitudes to the postoperative mortality and morbidity 
risks associated with surgery for lung cancer, and how these affected treatment 
decisions.  
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Methods 
Setting & participants 
Potential participants were identified from lung cancer MDT meetings at a tertiary 
referral centre in England. Eligible patients were over 18 years of age, able to provide 
written informed consent, had a diagnosis of lung cancer stage 1a to 3a (potentially 
resectable), and were aware of their diagnosis. Potential participants were not eligible if 
they were unable to communicate in English.  
Eligible patients were approached by a member of their clinical care team. Clinicians 
were given the option of declining to discuss the study with a patient if they felt it 
inappropriate (for example if the patient was very distressed about their diagnosis).  
Patients who expressed an interest in taking part were provided with an information 
sheet and gave verbal consent to being contacted by a researcher. Researchers allowed 
at least 24 hours after patients had received this written information before contacting 
them by telephone to ascertain whether they wished to participate in the study.  
A favourable opinion for the study was given by National Research Ethics Committee 
East Midlands – Nottingham 1 (Reference 12/EM/0123).   
Data collection 
Participants provided written informed consent before the interview. Face-to-face, semi-
structured interviews, lasting approximately 60 minutes (range 27-73 minutes) were 
conducted in the patient’s own home or in a private room at the research institution. 
Travel expenses were reimbursed.  At the start of the interview a confidentiality 
statement was read and participants were informed that they could withdraw from the 
study at any stage.  
A semi-structured discussion guide was developed to explore knowledge, beliefs and 
understanding associated with the lung cancer diagnosis and treatment plans, 
particularly focusing on surgery and the associated risks (Figure 1). The guide promoted 
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an open dialogue between patient and interviewer to allow the identification of new 
concepts.(4)  
Towards the end of the interview patients were asked to consider hypothetical scenarios 
where they were given different levels of 30-day mortality risk (2%, 5%, 15% or 
higher), 5-year survival (70%, 50% and 30%), and post-operative dyspnoea (using the 
MRC breathlessness scale, (5)). Visual aids were used to portray percentages and 
patients were asked to explain their reactions and attitudes to these hypothetical 
scenarios and how they might affect their decisions about treatment.  
Interviews were digitally audio-recorded and transcribed clean verbatim by an external 
specialist transcription company. 
Figure 1: Initial discussion guide 
 
Interviews were conducted by a clinical research fellow (HP) who is a speciality registrar 
in respiratory medicine. Shortly after each interview the patient’s hospital notes were 
accessed in order to complete a case report form which included demographic 
information and treatment plan.  
Recruitment, data collection and preliminary analysis of transcripts took place 
continuously until no new core themes were being interpreted within the dataset. 
Analysis 
Transcripts were checked for accuracy by the and data were analysed using the 
framework method as described by Gale et al.(6) Data from the first two interviews were 
discussed by members of the research team (HP, DRB, JD and MB) which resulted in 
some minor changes to the interview guide.  
Open coding was performed by the interviewer and themes and sub-themes were 
validated through independent coding by two different members of the research team 
(MB & LLJ). Data were charted into a framework matrix according to themes and sub-
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themes which facilitated comparisons of opinions from different participants. NVivo 
software (V10, QSR International Ltd, Melbourne, Australia) was used to assist with 
applying the analytical framework and constructing charts for each theme.  
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Results 
Sixty-two potentially eligible patients were identified from 38 MDT meetings between 
February and September 2013. Thirty-four of these patients could not be approached in 
line with the study protocol. The clinical care team approached 28 patients of whom two 
declined permission to be contacted by the researcher. Upon contact, seven patients (3 
male, 4 female, median age 60 years) declined to take part. Nineteen patients agreed to 
be interviewed; however, it was not possible to arrange an interview with four of these 
prior to their pre-operative assessment appointment. 
During one interview it became apparent that the participant may have some 
undiagnosed cognitive problems and therefore the interviewer did not feel it appropriate 
to continue the interview past the introduction and background questions. Therefore, 
complete interview data were available for 14 participants. Two patients had likely 
cancer based on CT and PET scans and the remainder had biopsy proven lung cancer. 
Recruitment in the context of the patient’s clinical pathway is depicted in Figure 2 and 
patient demographics are given in Table 1. 
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Figure 2: Recruitment diagram 
  N=15 % 
Age (years) Median 76 (Range 58-87) 
Sex Male 10 67 
 Female 5 33 
Stage 1a or 1b 8 53 
 2a or 2b 4 27 
 3a 3 20 
Clinicians seen 
prior to 
interview 
Respiratory physician 15 100 
Thoracic surgeon 13 93 
Clinical oncologist 2* 13 
Lung cancer nurse specialist 14 93 
Treatment plan Surgery 14 93 
 Radiotherapy 1 7 
*These patients saw both an oncologist and a surgeon prior to interview 
Table 1: Participant demographics 
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Four overall themes which provide insight into patients’ attitudes to risk and the decision 
making process surrounding surgery were identified (Figure 3).  
Theme Sub-themes 
1. Treatment options Alternatives to surgery  
Suitability for surgery  
2. Perioperative risks Knowledge & awareness of risks  
Acceptance of high mortality risk 
3. Long term outcomes Possibility of recurrence  
Long term morbidity risk  
4. Key people in decision making Surgeon-patient relationship  
Who makes the decision?  
 
Figure 3: Summary of main themes with sub-themes 
1. Treatment options 
Alternatives to surgery: Most patients were aware that chemotherapy and radiotherapy 
are treatments for cancer; in fact several had been treated with one or other modality 
for a different tumour site previously. In this context however, the majority reported 
that surgery was the only treatment option that had been discussed:  
“Because as I say everybody seems quite confident that surgery is the one thing for me.” 002 81F 
A few patients had met with a clinical oncologist (as well as a surgeon) prior to the 
interview; one was told that radiotherapy was not an option due to previous treatment 
but another elected to have radiotherapy rather than surgery because he felt that 
breathlessness was his main problem and having part or all of one lung removed would 
not help this symptom. 
Suitability for surgery: Most patients were relieved to hear that surgery was an option 
for them and seemed pleased that something was going to be done.  
 “I could have jumped up and hugged him…I thought “oh lovely”, something could be done about it, I 
can have it operated on” 024 70F 
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“So it was something of a relief to think that something was going to be done, practical… it was a relief to 
find out that they had a plan of action, and they didn't include chemical therapy” 010 64M 
The patient who ultimately chose radiotherapy, and the patients who had not seen a 
surgeon prior to the interview, did not express a view on hearing that they were suitable 
for surgery. Another patient felt “bitter” about being diagnosed with lung cancer after 
quite a prolonged diagnostic process, and stated that they were not happy about being 
suitable for surgery, because they did not want another operation. 
2. Perioperative risks  
Quotes to illustrate this subtheme are shown in Figure 4. 
Knowledge and awareness of risks: Most patients recalled specific mortality risk 
estimates given to them by the surgeon or respiratory physician, and many also said 
they had been told about possible early complications including infection, bleeding, air 
leaks and blood clots (Figure 4). Despite being able to recall their individual peri-
operative mortality risk estimates most patients said that they would rather not know 
about the risks or level of risk because they were going to have the operation anyway; 
knowing the risks would just cause additional worry. 
One patient who had not yet seen a surgeon did express a desire to know the risks 
because he wanted to know how likely he was to survive the operation; however, he also 
said that the level of risk would be unlikely to affect his decision as he had already made 
up his mind to have surgery if it was offered to him. 
Acceptance of high mortality risk: When presented with the hypothetical scenario of 
being told that their risk of dying within 30 days of the operation was 15% or higher, all 
but one patient said they were willing to take the risk, some even agreeing immediately 
that they would take a 50:50 chance. Typically, participants reported this was because 
they felt that surgery was the only option or that it was up to their doctors to decide 
whether surgery was the right treatment for them. Some patients went on to state that 
these risks were necessary for getting rid of cancer, or that there was no alternative; 
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whilst others adopted an ‘it won’t happen to me’ attitude, believing that the bad 
outcomes would happen to other people. 
 
Knowledge and awareness of risks: 
 
“Well they always tell you there’s risks don't they with all operations.  You sign the papers don't you, to 
say you're having it done whether there's risks or not. ….I don't think anybody would like to know 
really” 016 76F 
 
“He told me it’s 3% they lose in theatre which is 3 people out of 100, I said “it’s just your luck isn’t it?”, it 
is really.  I hope I don’t.” 004 81M 
 
“He told me all the things that they do normally tell you when you're having operation, so many deaths in 
so many, such and such a things and all that”    024 70F 
 
“….he’s telling me all the percentages, pneumonia and the bleeding and if they open up again, air leak on 
the lung, what would happen, just going through the scenario of the operation.” 026 66M 
 
“He said the risks of someone dying on the operating table was virtually negligible but there was a risk 
area and a couple of days after the operation, post-surgery and the things he pinpointed was either a 
serious infection or blood clotting” 010 64M 
 
Reasons given by patients for taking high surgical mortality risks: 
Getting rid of cancer 
“Radiotherapy yes, [friend]'s having that.  But if this will clear it, I'd sooner take that chance….. I know 
it could come back, but I want this removing now, I want it now removing as soon as possible” 028 81M 
 
“I think the quick and easy way, the quick and clean way, is get it cut out and be gone” 002 81F 
 
No alternative 
“I wouldn't like that but on the other hand, if I die if I don’t have the operation, what choice do I get?” 
013 76F 
 
“Obviously it’s not very comfortable is it [high mortality risk], but as regards that again, I haven’t got 
much choice, it’s got to be done”. 021 71M 
 
It won’t happen to me 
“Them two there could have something wrong with them.….they could have something else wrong with 
them, like some other disease or something like that which the surgeon didn’t know about or nobody’s 
told him about it” 003 79M 
 
“Well, I would think in my own case, I’m reasonably fit so I wouldn't expect it to happen to me, on some 
people that ... don't listen to advice then I would expect them to die as it were” 005 82M 
 
 
Figure 4: Quotes illustrating attitudes to perioperative risks 
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3. Long term outcomes 
Possibility of recurrence:  Most patients appeared to take long term survival after 
surgery for granted. When initially asked what they knew about the possibility of 
recurrence almost all denied any knowledge of this being likely. When this was raised as 
part of the scenarios however, all were actually aware that in some cases cancer can 
‘come back’ after surgery and they were not upset at this scenario, citing the media and 
friends/relatives as sources of this knowledge.   
Long term morbidity risk: Some patients felt that it was not worth living with major 
disability as a result of surgery, but most said they were prepared to accept this to live 
for longer. A patient who described quite disabling breathlessness (MRC 3) at the time of 
the interview was willing to accept deterioration to MRC 5 in exchange for removing the 
tumour; however, some patients who were not at all breathless also said they would be 
willing to accept MRC 5. A minority of patients were clear that severe post-operative 
breathlessness would be a reason to decline surgery. Some patients gave mixed 
messages regarding quality of life and the desire to live longer which seemed to be 
because they found it difficult to imagine being very breathless. 
4. Key people in decision making 
Surgeon-patient relationship: Patients reported unquestioning confidence in their 
surgeon’s ability which appeared to be due to their trust of the medical profession in 
general. Participants reported that having a good impression of the surgeon was 
important in establishing trust. A patient who had not yet seen the surgeon expressed a 
particular desire to know all about the surgeon:  
“Well, depending on how old he is I suppose to start with, how long he’s been a surgeon, how long he’s 
been doing these operations, how long he’s been in that department” 021 71M 
Who makes the decision?: Some participants indicated a preference that the decision 
regarding their treatment plan should be made for them by their doctors who “know 
best”. They implied this was closely related to confidence in their surgeon’s abilities and 
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trust that they would do what was best. Participants said that the doctor was better 
equipped than they were to decide on the treatment plan because of their medical 
knowledge and because they had all of the test results. One patient was particularly 
angry because he felt he had to make the decision himself when the doctors were in a 
much better position to do so. 
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Discussion  
Main findings 
The aim of this study was to explore patients’ attitudes to risk in lung cancer surgery and 
how these affected treatment decisions. Most patients were able to recall specific risk 
estimates and possible complications but despite this, many seemed not to want to know 
this information and in many cases decisions about surgery seemed to be separate from 
their understanding of mortality risk estimates. Decisions to have surgery appeared to 
have been made based on the desire for something to be done to get rid of the cancer, 
the perception that there was no alternative, and / or a willingness to follow whatever 
treatment pathway their doctor suggested, rather than weighing risks against benefits.  
Patients indicated that doctors know enough to make the right decision for them, and 
thus placed their trust in this knowledge and the surgeon’s ability. Although patients 
reported being willing to accept high levels of perioperative mortality risk when given 
hypothetical scenarios, this was in the context of a preference for clinicians to make the 
treatment decision for them, as well as a perception that there was no alternative. 
Patients in our study were prepared to live with the long term disability and 
breathlessness associated with lung resection in higher risk individuals; however, this 
may be because they could not imagine this level of disability or they did not believe that 
it would happen to them. Clinicians should therefore be aware that what may seem of 
importance to them may not be the same for their patient, whose decision may rest on 
the factors identified in this study combined with a limited appreciation of post-operative 
morbidity and long term survival. 
Findings in the context of existing literature 
There is very little previous work of this nature. In 1978, McNeil and colleagues 
published a study of risk-taking behaviour in people with lung cancer, specifically asking 
whether or not they would ‘gamble’ on 50:50 odds of different long term survival against 
early death in the context of treatment decisions.(7) They recruited 14 patients with 
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operable lung cancer, and questioned them after they had begun treatment; 8 had 
started radiotherapy and 6 had recently had an operation as primary treatment. This 
combination of timing of interview and the predominance of radiotherapy in the 
treatment plans potentially explains why the researchers found a degree of immediate 
risk aversion; older people in particular seemed to prefer treatments with a shorter 
overall survival but a smaller chance of immediate death. Since they did not use a 
qualitative methodology we are unable to understand why patients made these decisions 
or whether they understood the concepts of risk which they were asked to consider.  
Cykert et al conducted a survey of 386 US patients who had early-stage lung cancer, 
before their treatment plans were determined, and found that a perception of lower 
quality cancer communication was associated with decisions not to undergo lung cancer 
surgery.(8) This may reflect the importance of trust in the clinician’s ability to make the 
‘correct’ decision that was found in our study.  
The degree to which patients want to be informed and how much of a role they wish to 
play in making treatment decisions varies considerably.(9, 10) We found that patients 
were often keen to defer the weighing of risks against benefits to the ‘experts’ and many 
expressed a wish that the doctors decide on their treatment plan. It is possible that 
there is a generational difference in the level of information and degree of shared 
decision making that patients desire. People with lung cancer are predominantly from an 
older generation and this may partially explain their preferences. This idea is supported 
by the findings of Lonsdale et al in a questionnaire study where general surgical patients 
under the age of 50 were more positive than older patients in their desire to know about 
the risks of anaesthesia.(9) It is also likely, however, that cancer patients are different 
to general surgical patients and in a study of 1012 women with breast cancer, in which 
the median age of respondents was 58 years, only 22% wanted to select their own 
treatment; 34% wanted the doctors to make the decision with the remainder preferring 
a collaboration.(10)  
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Strengths & Weaknesses 
The main strengths of our study are the novelty of the research and the use of 
qualitative data collection methods to explore the reasons behind attitudes to risk in lung 
cancer patients. Our sample is relatively small, participants were recruited from a single 
site and the demographic of the patients who participated differed from those who 
declined to be contacted or interviewed (self-selection bias). Sampling in qualitative 
research is not designed to be representative of a wider population;(11) however, we 
acknowledge that the views of these participants may differ from those who declined to 
take part. Patients who were in favour of surgery may have been more likely to agree to 
take part in the study and only one of the patients interviewed decided not to have 
surgery. This is a relatively unusual treatment choice in our clinical experience and 
therefore we did not think it feasible to continue recruitment with a view to interviewing 
more patients who had made a similar choice. 
We interviewed patients after they were given a diagnosis of lung cancer and before they 
had their pre-operative assessment. This timescale ensured that patients’ views were 
unaffected by the outcome of any treatment; however, we acknowledge that patients 
may have received more information and had further discussions with the surgeon after 
they participated in the study, potentially even changing their treatment plan, at the 
pre-operative assessment visit.  
The background of the interviewer is an important consideration in studies such as this. 
Our interviewer was medically trained but was intentionally not aware of details of cases 
prior to the interview. We acknowledge that the interviewer’s own attitudes and pre-
conceptions about risks of surgery may have influenced the direction of the discussion.  
Clinical relevance & conclusions 
One of the next steps in improving lung cancer survival may be to offer surgery to an 
increasing number of patients with borderline fitness levels who may be at higher risk of 
perioperative mortality and postoperative morbidity. Our study suggests that investment 
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in the doctor-patient relationship is important when helping patients to decide whether 
to accept these risks, and that clinicians should be aware that patients may wish to defer 
decisions about treatment to their medical team. This has implications for the process of 
informed consent and further research is needed exploring the communication of risk in 
this context.  
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